Premium
Rituximab, bendamustine and cytarabine ( R‐BAC ) in patients with relapsed‐refractory aggressive B ‐ and T ‐cell lymphoma
Author(s) -
Tisi M.C.,
Paolini R.,
Piazza F.,
Ravelli E.,
Carli G.,
Perbellini O.,
Ruggeri M.,
Visco C.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_94
Subject(s) - bendamustine , rituximab , medicine , cytarabine , mantle cell lymphoma , lymphoma , oncology , gastroenterology , diffuse large b cell lymphoma , aggressive lymphoma , chemotherapy